7Baggers
 Aytu BioPharma, Inc. (NASDAQ:AYTU) Q1 2026 Earnings Call Transcript  Insider Monkey Sat, 15 Nov 2025 13:35:01 GMT
 Aytu BioPharma Reports Q1 2026 Earnings and EXXUA Launch Plans  TipRanks Fri, 14 Nov 2025 05:28:53 GMT
 Aytu BioPharma Inc (AYTU) Q1 2026 Earnings Call Highlights: Stro  GuruFocus Fri, 14 Nov 2025 05:04:50 GMT
 Transcript : Aytu BioPharma, Inc., Q1 2026 Earnings Call, Nov 13, 2025  MarketScreener Fri, 14 Nov 2025 02:50:56 GMT
 Aytu BioPharma Inc. (AYTU) Reports Q1 Loss, Tops Revenue Estimates  sharewise.com Thu, 13 Nov 2025 23:37:30 GMT
 AYTU BIOPHARMA, INC SEC 10-Q Report  TradingView Thu, 13 Nov 2025 21:13:00 GMT
 Insights into Aytu BioPharma's Upcoming Earnings  Benzinga Wed, 12 Nov 2025 16:04:16 GMT
 published on: 2025-11-05 22:25:58  newser.com Thu, 06 Nov 2025 04:25:58 GMT
 published on: 2025-11-04 05:56:53  newser.com Tue, 04 Nov 2025 11:56:53 GMT
 published on: 2025-11-01 08:49:06  newser.com Sat, 01 Nov 2025 13:49:06 GMT
 published on: 2025-11-01 06:04:31  newser.com Sat, 01 Nov 2025 11:04:31 GMT
 published on: 2025-10-31 04:46:09  newser.com Fri, 31 Oct 2025 09:46:09 GMT

Aytu Biopharma, Inc
(NASDAQ:AYTU) 

AYTU stock logo

Aytu Biopharma, Inc., a specialty pharmaceutical company, focuses on developing and commercializing novel products in the field of hypogonadism (low testosterone), cough and upper respiratory symptoms, insomnia, and male infertility in the United States and internationally. The company markets Nates...

Founded: 2002
Full Time Employees: 75
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends